Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 288

1.

Clinical outcome and toxicity after simultaneous integrated boost IMRT in head and neck squamous cell cancer patients.

Dragan T, Beauvois S, Moreau M, Paesmans M, Vandekerkhove C, Cordier L, Van Gestel D.

Oral Oncol. 2019 Nov;98:132-140. doi: 10.1016/j.oraloncology.2019.09.012. Epub 2019 Oct 3.

PMID:
31586895
2.

Retrospective evaluation of the safety of low-level laser therapy/photobiomodulation in patients with head/neck cancer.

Genot-Klastersky MT, Paesmans M, Ameye L, Kayumba A, Beauvois S, Dragan T, Van Gestel D, Lalami Y, Klastersky JA.

Support Care Cancer. 2019 Sep 9. doi: 10.1007/s00520-019-05041-3. [Epub ahead of print]

PMID:
31502227
3.

Tumor infiltrating B-cells signal functional humoral immune responses in breast cancer.

Garaud S, Buisseret L, Solinas C, Gu-Trantien C, de Wind A, Van den Eynden G, Naveaux C, Lodewyckx JN, Boisson A, Duvillier H, Craciun L, Ameye L, Veys I, Paesmans M, Larsimont D, Piccart-Gebhart M, Willard-Gallo K.

JCI Insight. 2019 Aug 13;5. pii: 129641. doi: 10.1172/jci.insight.129641.

4.

CTCs as a prognostic and predictive biomarker for stage II/III Colon Cancer: a companion study to the PePiTA trial.

Rothé F, Maetens M, Rouas G, Paesmans M, Van den Eynde M, Van Laethem JL, Vergauwe P, Deboever G, Bareche Y, Vandeputte C, Ignatiadis M, Hendlisz A.

BMC Cancer. 2019 Apr 3;19(1):304. doi: 10.1186/s12885-019-5528-1.

5.

Assessment of bone quality with trabecular bone score in type 2 diabetes mellitus: A study from the FRISBEE cohort.

Baleanu F, Bergmann P, Hambye AS, Dekelver C, Iconaru L, Cappelle SI, Moreau M, Paesmans M, Karmali R, Body JJ.

Int J Clin Pract. 2019 May;73(5):e13347. doi: 10.1111/ijcp.13347. Epub 2019 Apr 17.

PMID:
30912212
6.

[Lung cancer: Prognosis in intensive care depends mainly on the acute complication].

Gorham J, Ameye L, Paesmans M, Berghmans T, Sculier JP, Meert AP.

Rev Mal Respir. 2019 Mar;36(3):333-341. doi: 10.1016/j.rmr.2018.05.014. Epub 2019 Mar 18. French.

PMID:
30898468
7.

Combining 18F-FDG PET/CT-Based Metabolically Active Tumor Volume and Circulating Cell-Free DNA Significantly Improves Outcome Prediction in Chemorefractory Metastatic Colorectal Cancer.

Woff E, Kehagias P, Vandeputte C, Ameye L, Guiot T, Paesmans M, Hendlisz A, Flamen P.

J Nucl Med. 2019 Oct;60(10):1366-1372. doi: 10.2967/jnumed.118.222919. Epub 2019 Mar 8.

PMID:
30850494
8.

Prognostic value of adipose tissue and muscle mass in advanced colorectal cancer: a post hoc analysis of two non-randomized phase II trials.

Charette N, Vandeputte C, Ameye L, Bogaert CV, Krygier J, Guiot T, Deleporte A, Delaunoit T, Geboes K, Van Laethem JL, Peeters M, Demolin G, Holbrechts S, Flamen P, Paesmans M, Hendlisz A.

BMC Cancer. 2019 Feb 12;19(1):134. doi: 10.1186/s12885-019-5319-8.

9.

Predictive factors for cancer-associated thrombosis in a large retrospective single-center study.

Haltout J, Awada A, Paesmans M, Moreau M, Klastersky J, Machiels G, Ignatiadis M, Kotecki N.

Support Care Cancer. 2019 Apr;27(4):1163-1170. doi: 10.1007/s00520-018-4602-6. Epub 2019 Jan 4.

PMID:
30610431
10.

Clinical outcomes of laryngopharyngeal reflux treatment: A systematic review and meta-analysis.

Lechien JR, Saussez S, Schindler A, Karkos PD, Hamdan AL, Harmegnies B, De Marrez LG, Finck C, Journe F, Paesmans M, Vaezi MF.

Laryngoscope. 2019 May;129(5):1174-1187. doi: 10.1002/lary.27591. Epub 2018 Dec 30.

PMID:
30597577
11.

Achieving Thoracic Oncology data collection in Europe: a precursor study in 35 Countries.

Rich A, Baldwin D, Alfageme I, Beckett P, Berghmans T, Brincat S, Burghuber O, Corlateanu A, Cufer T, Damhuis R, Danila E, Domagala-Kulawik J, Elia S, Gaga M, Goksel T, Grigoriu B, Hillerdal G, Huber RM, Jakobsen E, Jonsson S, Jovanovic D, Kavcova E, Konsoulova A, Laisaar T, Makitaro R, Mehic B, Milroy R, Moldvay J, Morgan R, Nanushi M, Paesmans M, Putora PM, Samarzija M, Scherpereel A, Schlesser M, Sculier JP, Skrickova J, Sotto-Mayor R, Strand TE, Van Schil P, Blum TG.

BMC Cancer. 2018 Nov 20;18(1):1144. doi: 10.1186/s12885-018-5009-y.

12.

Risk factors for the development of brain metastases in patients with HER2-positive breast cancer.

Maurer C, Tulpin L, Moreau M, Dumitrescu C, de Azambuja E, Paesmans M, Nogaret JM, Piccart MJ, Awada A.

ESMO Open. 2018 Oct 24;3(6):e000440. doi: 10.1136/esmoopen-2018-000440. eCollection 2018.

13.

ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe.

Rich AL, Baldwin DR, Beckett P, Berghmans T, Boyd J, Faivre-Finn C, Galateau-Salle F, Gamarra F, Grigoriu B, Hansen NG, Hardavella G, Jakobsen E, Jovanovic D, Konsoulova A, Massard G, McPhelim J, Meert AP, Milroy R, Mutti L, Paesmans M, Peake MD, Putora PM, de Ruysscher DKM, Sculier JP, Scherpereel A, Subotic DR, Van Schil P, Blum TG.

Eur Respir J. 2018 Dec 20;52(6). pii: 1800610. doi: 10.1183/13993003.00610-2018. Print 2018 Dec.

PMID:
30361252
15.

Validation of Metabolically Active Tumor Volume and Total Lesion Glycolysis as 18F-FDG PET/CT–derived Prognostic Biomarkers in Chemorefractory Metastatic Colorectal Cancer

Woff E, Hendlisz A, Ameye L, Garcia C, Kamoun T, Guiot T, Paesmans M, Flamen P.

J Nucl Med. 2019 Feb 1;60(2):178-184. doi: 10.2967/jnumed.118.210161. Epub 2018 Jun 29.

PMID:
29959212
16.

[Diagnostic approach of an IgM monoclonal gammopathy and clinical importance of gene MYD88 L265P mutation].

Cilla N, Vercruyssen M, Ameye L, Paesmans M, de Wind A, Heimann P, Meuleman N, Bron D.

Rev Med Brux. 2018 May 30. doi: 10.30637/2018.17-090. [Epub ahead of print] French.

PMID:
29869471
17.

Circulating tumor DNA in early response assessment and monitoring of advanced colorectal cancer treated with a multi-kinase inhibitor.

Vandeputte C, Kehagias P, El Housni H, Ameye L, Laes JF, Desmedt C, Sotiriou C, Deleporte A, Puleo F, Geboes K, Delaunoit T, Demolin G, Peeters M, D'Hondt L, Janssens J, Carrasco J, Marechal R, Galdon MG, Heimann P, Paesmans M, Flamen P, Hendlisz A.

Oncotarget. 2018 Apr 3;9(25):17756-17769. doi: 10.18632/oncotarget.24879. eCollection 2018 Apr 3.

18.

Postmastectomy Radiation Therapy in Women with T1-T2 Tumors and 1 to 3 Positive Lymph Nodes: Analysis of the Breast International Group 02-98 Trial.

Zeidan YH, Habib JG, Ameye L, Paesmans M, de Azambuja E, Gelber RD, Campbell I, Nordenskjöld B, Gutiérez J, Anderson M, Lluch A, Gnant M, Goldhirsch A, Di Leo A, Joseph DJ, Crown J, Piccart-Gebhart M, Francis PA.

Int J Radiat Oncol Biol Phys. 2018 Jun 1;101(2):316-324. doi: 10.1016/j.ijrobp.2018.01.105. Epub 2018 Feb 6.

PMID:
29534902
19.

A phase III randomised study comparing concomitant radiochemotherapy with cisplatin and docetaxel as induction versus consolidation treatment in patients with locally advanced unresectable non-small cell lung cancer.

Sculier JP, Lafitte JJ, Berghmans T, Meert AP, Scherpereel A, Roelandts M, Van Cutsem O, Colinet B, Bonduelle Y, Giner V, Paesmans M, Leclercq N, Van Houtte P.

Lung Cancer. 2018 Mar;117:32-37. doi: 10.1016/j.lungcan.2017.12.016. Epub 2018 Jan 31.

PMID:
29496253
20.

Response.

Lambertini M, Ameye L, Paesmans M, Peccatori FA, Azim HA Jr.

J Natl Cancer Inst. 2018 Aug 1;110(8):919-920. doi: 10.1093/jnci/djx292. No abstract available.

PMID:
29329404
21.

Are concurrent systematic cores needed at the time of targeted biopsy in patients with prior negative prostate biopsies?

Albisinni S, Aoun F, Noel A, El Rassy E, Lemort M, Paesmans M, van Velthoven R, Roumeguère T, Peltier A.

Prog Urol. 2018 Jan;28(1):18-24. doi: 10.1016/j.purol.2017.10.001. Epub 2017 Dec 6.

PMID:
29203158
22.

Distribution of clinical risk factors for fracture in a Brussels cohort of postmenopausal women: The FRISBEE study and comparison with other major cohort studies.

Cappelle SI, Ramon I, Dekelver C, Rozenberg S, Baleanu F, Karmali R, Rubinstein M, Tondeur M, Moreau M, Paesmans M, Bergmann P, Body JJ.

Maturitas. 2017 Dec;106:1-7. doi: 10.1016/j.maturitas.2017.08.010. Epub 2017 Aug 24.

PMID:
29150162
23.

Clinical significance of CD73 in triple-negative breast cancer: multiplex analysis of a phase III clinical trial.

Buisseret L, Pommey S, Allard B, Garaud S, Bergeron M, Cousineau I, Ameye L, Bareche Y, Paesmans M, Crown JPA, Di Leo A, Loi S, Piccart-Gebhart M, Willard-Gallo K, Sotiriou C, Stagg J.

Ann Oncol. 2018 Apr 1;29(4):1056-1062. doi: 10.1093/annonc/mdx730.

24.

Long-term Safety of Pregnancy Following Breast Cancer According to Estrogen Receptor Status.

Lambertini M, Kroman N, Ameye L, Cordoba O, Pinto A, Benedetti G, Jensen MB, Gelber S, Del Grande M, Ignatiadis M, de Azambuja E, Paesmans M, Peccatori FA, Azim HA Jr.

J Natl Cancer Inst. 2018 Apr 1;110(4):426-429. doi: 10.1093/jnci/djx206.

25.

A Phase III Randomized Study Comparing a Chemotherapy with Cisplatin and Etoposide to a Etoposide Regimen without Cisplatin for Patients with Extensive Small-Cell Lung Cancer.

Berghmans T, Scherpereel A, Meert AP, Giner V, Lecomte J, Lafitte JJ, Leclercq N, Paesmans M, Sculier JP; European Lung Cancer Working Party (ELCWP).

Front Oncol. 2017 Sep 19;7:217. doi: 10.3389/fonc.2017.00217. eCollection 2017.

26.

Intravenous iron therapy for anemic cancer patients: a review of recently published clinical studies.

Lebrun F, Klastersky J, Levacq D, Wissam Y, Paesmans M.

Support Care Cancer. 2017 Jul;25(7):2313-2319. doi: 10.1007/s00520-017-3672-1. Epub 2017 Apr 7. Review.

PMID:
28386789
27.

The Prognostic Role of Androgen Receptor in Patients with Early-Stage Breast Cancer: A Meta-analysis of Clinical and Gene Expression Data.

Bozovic-Spasojevic I, Zardavas D, Brohée S, Ameye L, Fumagalli D, Ades F, de Azambuja E, Bareche Y, Piccart M, Paesmans M, Sotiriou C.

Clin Cancer Res. 2017 Jun 1;23(11):2702-2712. doi: 10.1158/1078-0432.CCR-16-0979. Epub 2016 Nov 9.

28.

First 200 consecutive transumbilical single-incision laparoscopic TEPs.

Dapri G, Gerard L, Paesmans M, Cadière GB, Saussez S.

Hernia. 2017 Feb;21(1):29-35. doi: 10.1007/s10029-016-1564-9. Epub 2016 Dec 23.

PMID:
28012031
29.

Are Intensive Cares Worthwhile for Breast Cancer Patients: The Experience of an Oncological ICU.

Destrebecq V, Lieveke A, Berghmans T, Paesmans M, Sculier JP, Meert AP.

Front Med (Lausanne). 2016 Oct 31;3:50. eCollection 2016.

30.

Re: Prognostic value of CALR vs. JAK2V617F mutations on splenomegaly, leukemic transformation, thrombosis, and overall survival in patients with primary fibrosis: a meta-analysis.

Kourie HR, Ameye L, Paesmans M, Bron D.

Ann Hematol. 2016 Dec;95(12):2105-2106. Epub 2016 Sep 29. No abstract available.

PMID:
27686082
31.

The prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patients.

Lambertini M, Pinto AC, Ameye L, Jongen L, Del Mastro L, Puglisi F, Poggio F, Bonotto M, Floris G, Van Asten K, Wildiers H, Neven P, de Azambuja E, Paesmans M, Azim HA Jr.

Br J Cancer. 2016 Dec 6;115(12):1471-1478. doi: 10.1038/bjc.2016.359. Epub 2016 Nov 1.

32.

Salvage esophagectomy after failure of definitive radiochemotherapy for esophageal cancer.

Farinella E, Safar A, Nasser HA, Bouazza F, Liberale G, Paesmans M, Marechal R, Van Laethem JL, Hendlisz A, VanHoutte P, El Nakadi I.

J Surg Oncol. 2016 Dec;114(7):833-837. doi: 10.1002/jso.24429. Epub 2016 Oct 25.

PMID:
27778349
33.

VAC chemotherapy with valproic acid for refractory/relapsing small cell lung cancer: a phase II study.

Berghmans T, Lafitte JJ, Scherpereel A, Ameye L, Paesmans M, Meert AP, Colinet B, Tulippe C, Willems L, Leclercq N, Sculier JP; European Lung Cancer Working Party.

ERJ Open Res. 2015 Oct 19;1(2). pii: 00029-2015. eCollection 2015 Oct.

34.

Biomarkers for adverse events associated with immune checkpoint inhibitors.

Kourie HR, Paesmans M, Klastersky J.

Biomark Med. 2016 Oct;10(10):1029-1031. Epub 2016 Sep 14. No abstract available.

PMID:
27626646
35.

Testicular germ cell tumor: Short and long-term side effects of treatment among survivors.

Gil T, Sideris S, Aoun F, van Velthoven R, Sirtaine N, Paesmans M, Ameye L, Awada A, Devriendt D, Peltier A.

Mol Clin Oncol. 2016 Sep;5(3):258-264. Epub 2016 Jul 14.

36.

Vulnerabilities in Older Patients when Cancer Treatment is Initiated: Does a Cognitive Impairment Impact the Two-Year Survival?

Libert Y, Dubruille S, Borghgraef C, Etienne AM, Merckaert I, Paesmans M, Reynaert C, Roos M, Slachmuylder JL, Vandenbossche S, Bron D, Razavi D.

PLoS One. 2016 Aug 1;11(8):e0159734. doi: 10.1371/journal.pone.0159734. eCollection 2016.

37.

Feasibility Study of EndoTAG-1, a Tumor Endothelial Targeting Agent, in Combination with Paclitaxel followed by FEC as Induction Therapy in HER2-Negative Breast Cancer.

Ignatiadis M, Zardavas D, Lemort M, Wilke C, Vanderbeeken MC, D'Hondt V, De Azambuja E, Gombos A, Lebrun F, Dal Lago L, Bustin F, Maetens M, Ameye L, Veys I, Michiels S, Paesmans M, Larsimont D, Sotiriou C, Nogaret JM, Piccart M, Awada A.

PLoS One. 2016 Jul 25;11(7):e0154009. doi: 10.1371/journal.pone.0154009. eCollection 2016.

38.

Improved survival in patients with CALR1 compared to CALR2 mutated primary myelofibrosis: a meta-analysis.

Kourie HR, Ameye L, Paesmans M, Bron D.

Br J Haematol. 2017 Dec;179(5):846-848. doi: 10.1111/bjh.14259. Epub 2016 Jul 19. No abstract available.

PMID:
27434541
39.

Predicting microbiologically defined infection in febrile neutropenic episodes in children: global individual participant data multivariable meta-analysis.

Phillips RS, Sung L, Ammann RA, Riley RD, Castagnola E, Haeusler GM, Klaassen R, Tissing WJ, Lehrnbecher T, Chisholm J, Hakim H, Ranasinghe N, Paesmans M, Hann IM, Stewart LA.

Br J Cancer. 2016 Jun 14;114(12):e17. doi: 10.1038/bjc.2016.137. Epub 2016 May 26. No abstract available.

40.

Results of the Belgian expanded access program of eribulin in the treatment of metastatic breast cancer closely mirror those of the pivotal phase III trial.

Aftimos P, Polastro L, Ameye L, Jungels C, Vakili J, Paesmans M, van den Eerenbeemt J, Buttice A, Gombos A, de Valeriola D, Gil T, Piccart-Gebhart M, Awada A.

Eur J Cancer. 2016 Jun;60:117-24. doi: 10.1016/j.ejca.2016.03.010. Epub 2016 Apr 20.

PMID:
27107326
41.

[The Glasgow inflammatory score and lung cancer: A predictor of admissions to emergency units].

Gorham J, Ameye L, Paesmans M, Berghmans T, Sculier JP, Meert AP.

Rev Mal Respir. 2016 Nov;33(9):759-765. doi: 10.1016/j.rmr.2016.02.004. Epub 2016 Mar 24. French.

PMID:
27017064
42.

Predicting microbiologically defined infection in febrile neutropenic episodes in children: global individual participant data multivariable meta-analysis.

Phillips RS, Sung L, Ammann RA, Riley RD, Castagnola E, Haeusler GM, Klaassen R, Tissing WJ, Lehrnbecher T, Chisholm J, Hakim H, Ranasinghe N, Paesmans M, Hann IM, Stewart LA; PICNICC Collaboration.

Br J Cancer. 2016 Mar 15;114(6):623-30. doi: 10.1038/bjc.2016.28. Epub 2016 Mar 8. Erratum in: Br J Cancer. 2016 Jun 14;114(12):e17.

43.

Improved Survival of Calreticulin-Mutated Patients Compared With Janus Kinase 2 in Primary Myelofibrosis: A Meta-Analysis.

Kourie HR, Ameye L, Paesmans M, Bron D.

Clin Lymphoma Myeloma Leuk. 2016 May;16(5):264-8. doi: 10.1016/j.clml.2016.01.009. Epub 2016 Feb 6.

PMID:
26935576
44.

The current use and attitudes towards tumor genome sequencing in breast cancer.

Gingras I, Sonnenblick A, de Azambuja E, Paesmans M, Delaloge S, Aftimos P, Piccart MJ, Sotiriou C, Ignatiadis M, Azim HA Jr.

Sci Rep. 2016 Mar 2;6:22517. doi: 10.1038/srep22517.

45.

[Difficulties and limitations in conducting translational research in thoracic oncology. A practical example].

Meert AP, Ameye L, Leclercq N, Paesmans M, Remmelink M, Sculier JP, Berghmans T.

Rev Mal Respir. 2016 Sep;33(7):594-9. doi: 10.1016/j.rmr.2015.10.744. Epub 2016 Jan 6. French.

PMID:
26777111
46.

Results of a comparative analysis of magnetic resonance imaging-targeted versus three-dimensional transrectal ultrasound prostate biopsies: Size does matter.

Peltier A, Aoun F, Albisinni S, Marcelis Q, Ledinh D, Paesmans M, Lemort M, van Velthoven R.

Scand J Urol. 2016 Jun;50(3):144-8. doi: 10.3109/21681805.2015.1118408. Epub 2016 Jan 12.

PMID:
26754860
47.

Opioid-free anesthesia: what about patient comfort? A prospective, randomized, controlled trial.

Hontoir S, Saxena S, Gatto P, Khalife M, Ben Aziz AM, Paesmans M, Sosnowski M.

Acta Anaesthesiol Belg. 2016;67(4):183-190.

PMID:
29873988
48.

Menopausal hormone therapy use in relation to breast cancer incidence in 11 European countries.

Antoine C, Ameye L, Paesmans M, de Azambuja E, Rozenberg S.

Maturitas. 2016 Feb;84:81-8. doi: 10.1016/j.maturitas.2015.11.010. Epub 2015 Nov 25.

PMID:
26654400
49.

[Implementation of an oncological care program in a multidisciplinary clinic].

Sculier JP, Leclercq N, Meert AP, Paesmans M, Berghmans T.

Rev Mal Respir. 2016 Sep;33(7):600-6. doi: 10.1016/j.rmr.2015.10.741. Epub 2015 Nov 21. French.

PMID:
26611198
50.

Should the treatment of advanced lepidic adenocarcinoma be adapted to the pathological subtype?

Paesmans M.

Eur Respir J. 2015 Nov;46(5):1259-61. doi: 10.1183/13993003.01563-2015. No abstract available.

Supplemental Content

Loading ...
Support Center